Andrew J Pollard Selected Research

Andrew J Pollard Research Topics

Disease

98	Infections 04/2024 - 06/2002
65	Typhoid Fever (Typhoid) 04/2024 - 06/2007
36	COVID-19 05/2024 - 01/2020
29	Meningococcal Infections 01/2023 - 02/2003
22	Diphtheria 07/2023 - 04/2005
19	Fever (Fevers) 11/2023 - 09/2010
17	Whooping Cough (Pertussis) 07/2023 - 04/2005
16	Bacterial Infections (Bacterial Infection) 11/2023 - 12/2005
15	Tetanus 07/2023 - 04/2005
13	Pneumococcal Infections 02/2024 - 01/2007
12	Poliomyelitis (Polio) 01/2022 - 04/2005
11	Communicable Diseases (Infectious Diseases) 01/2022 - 05/2011
10	Measles 12/2022 - 06/2013
9	Meningitis 01/2024 - 03/2010
9	Human Influenza (Influenza) 01/2021 - 03/2012
8	Virus Diseases (Viral Diseases) 11/2023 - 08/2016
8	Mumps 12/2022 - 06/2013
8	Pain (Aches) 11/2022 - 01/2008
7	Hepatitis B 01/2021 - 03/2008
6	Respiratory Syncytial Virus Infections 01/2024 - 01/2019
6	Rubella (German Measles) 01/2022 - 06/2015
6	Vaccinia 10/2021 - 04/2016
5	Breakthrough Infections 04/2024 - 01/2022
5	Encephalitis (Encephalitis, Rasmussen) 11/2023 - 01/2017
5	Pharyngitis (Sore Throat) 01/2021 - 09/2010
5	Bacterial Meningitis 12/2018 - 01/2009
4	Pneumonia (Pneumonitis) 02/2024 - 01/2009
4	Japanese Encephalitis 04/2023 - 10/2017
4	Headache (Headaches) 12/2021 - 08/2006
4	Sepsis (Septicemia) 01/2019 - 11/2010
4	Disease Susceptibility (Diathesis) 01/2018 - 10/2004
4	Bacteremia 01/2017 - 05/2014
3	Viral Meningitis 01/2024 - 03/2015
3	Salmonella Infections (Salmonellosis) 01/2020 - 03/2013
3	Aphthous Stomatitis (Aphthous Ulcer) 12/2019 - 09/2010
3	Lymphadenitis (Adenitis) 12/2019 - 09/2010
3	Inflammation (Inflammations) 09/2015 - 05/2010
2	Pneumococcal Pneumonia 02/2024 - 01/2019
2	Autoimmune Diseases of the Nervous System 11/2023 - 01/2023
2	Q Fever (Fever, Q) 01/2023 - 01/2022
2	Vaccine-Preventable Diseases 01/2022 - 01/2020
2	Paratyphoid Fever 12/2021 - 01/2017
2	Asymptomatic Infections 11/2021 - 01/2018
2	Ageusia (Hypogeusia) 10/2021 - 01/2021
2	Cough 10/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

177	VaccinesIBA 05/2024 - 06/2002
72	Conjugate VaccinesIBA 04/2024 - 04/2005
31	AntigensIBA 04/2024 - 01/2006
29	Proteins (Proteins, Gene)FDA Link 05/2024 - 07/2004
27	Polysaccharides (Glycans)IBA 02/2024 - 02/2003
20	ChAdOx1 nCoV-19IBA 04/2024 - 01/2020
19	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 03/2010
18	AntibodiesIBA 01/2023 - 04/2005
15	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2023 - 04/2005
13	Immunoglobulin G (IgG)IBA 02/2024 - 12/2010
11	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2010
10	COVID-19 VaccinesIBA 04/2024 - 01/2020
10	Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)FDA Link 12/2021 - 06/2015
7	TCVSIBA 12/2023 - 10/2018
6	Immunoglobulins (Immunoglobulin)IBA 11/2023 - 12/2015
6	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2018 - 03/2012
5	MenACWYIBA 12/2022 - 01/2008
5	CytokinesIBA 01/2022 - 05/2004
5	FluoroquinolonesIBA 01/2022 - 01/2018
5	GlycoconjugatesIBA 12/2021 - 09/2006
5	Glycoproteins (Glycoprotein)IBA 01/2021 - 04/2016
5	Capsules (Microcapsules)IBA 08/2012 - 02/2003
4	RNA (Ribonucleic Acid)IBA 04/2024 - 08/2016
4	LipopolysaccharidesIBA 01/2023 - 05/2014
4	Meningococcal Vaccines (Meningococcal Vaccine)IBA 11/2022 - 03/2016
4	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2020 - 11/2016
3	AutoantibodiesIBA 11/2023 - 05/2010
3	N-methyl-valyl-amiclenomycin (BA 2)IBA 10/2023 - 01/2022
3	Combined VaccinesIBA 10/2023 - 02/2015
3	Attenuated VaccinesIBA 01/2023 - 01/2017
3	Antiviral Agents (Antivirals)IBA 10/2022 - 01/2017
3	Carrier Proteins (Binding Protein)IBA 10/2021 - 01/2016
3	Nucleic AcidsIBA 10/2021 - 01/2021
3	smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA 01/2021 - 04/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2004
3	NucleoproteinsIBA 01/2021 - 06/2012
3	C-Reactive ProteinIBA 01/2021 - 03/2015
3	Neutralizing AntibodiesIBA 01/2021 - 04/2016
3	Immunoglobulin A (IgA)IBA 01/2019 - 01/2015
3	EnzymesIBA 05/2017 - 06/2012
3	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 05/2014 - 03/2009
3	Phosphates (Orthophosphate)IBA 01/2014 - 04/2005
2	S-268019-b COVID-19 vaccineIBA 05/2024 - 01/2024
2	MicroRNAs (MicroRNA)IBA 04/2024 - 01/2017
2	Intravenous Immunoglobulins (IVIG)FDA Link 11/2023 - 10/2017
2	N-(2-cyanoethylene)urea (BA 1)IBA 10/2023 - 01/2022
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 01/2022
2	EpitopesIBA 01/2022 - 01/2018
2	4CMenB vaccineIBA 01/2022 - 04/2015

Therapy/Procedure

9	Therapeutics 09/2023 - 05/2004
4	Length of Stay 01/2024 - 03/2015
4	Critical Care (Surgical Intensive Care) 12/2022 - 08/2016
3	Tonsillectomy 12/2019 - 09/2010
2	Intramuscular Injections 01/2024 - 01/2020
2	Injections 01/2023 - 01/2021